Gail K. Naughton, Director at CYTORI THERAPEUTICS, INC. (CYTX), bought 1,000 shares at $2.10 ($2K) on 2016-06-14, disclosed to the SEC on 2016-06-15.
Open-market purchase of $2k CYTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| BCR | SELL | 2016-02-03 | $219K | — | Filing → |
| BCR | SELL | 2015-10-28 | $447K | — | Filing → |
| BCR | SELL | 2015-04-29 | $130K | — | Filing → |